ACCEL Lite: Improving characterization of Stage A and B HF by adding Strain
Earlier detection of people at risk of HF would enable cardioprotection to be initiated earlier and damage avoided. Current imaging tools (eg. ejection fraction) are not sensitive enough to identify early disease. While GLS has been shown to predict outcomes, this study shows that its use improves the predictive power of the current definition of stage B HF.
In this interview, Professor Tom Marwick MBBS, PhD, MPH, FAHMS and John Gorcsan III MD, FACC discuss improving characterization of Stage A and B HF by adding strain.
- Potter and Marwick – EJHF 2022 https://pubmed.ncbi.nlm.nih.gov/35014128/
- Haji and Marwick – JACCi 2022 https://pubmed.ncbi.nlm.nih.gov/35926896/
- Yang and Marwick – JACCi 2017 https://pubmed.ncbi.nlm.nih.gov/28279368/
Keywords: ACCELLite, Heart Failure
< Back to Listings